A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients by Quach, Susan et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Health Services Research
Open Access Research article
A comparison between the APACHE II and Charlson Index Score 
for predicting hospital mortality in critically ill patients
Susan Quach1, Deirdre A Hennessy1,2, Peter Faris1, Andrew Fong1, 
Hude Quan1 and Christopher Doig*1,2
Address: 1Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada and 2Department of Critical Care Medicine, 
University of Calgary, Calgary, Alberta, Canada
Email: Susan Quach - susan.quach@phac-aspc.gc.ca; Deirdre A Hennessy - dhenness@ucalgary.ca; Peter Faris - faris@ucalgary.ca; 
Andrew Fong - andrew.fong@albertahealthservices.ca; Hude Quan - hquan@ucalgary.ca; 
Christopher Doig* - chip.doig@albertahealthservices.ca
* Corresponding author    
Abstract
Background: Risk adjustment and mortality prediction in studies of critical care are usually
performed using acuity of illness scores, such as Acute Physiology and Chronic Health Evaluation
II (APACHE II), which emphasize physiological derangement. Common risk adjustment systems
used in administrative datasets, like the Charlson index, are entirely based on the presence of co-
morbid illnesses. The purpose of this study was to compare the discriminative ability of the
Charlson index to the APACHE II in predicting hospital mortality in adult multisystem ICU patients.
Methods: This was a population-based cohort design. The study sample consisted of adult (>17
years of age) residents of the Calgary Health Region admitted to a multisystem ICU between April
2002 and March 2004. Clinical data were collected prospectively and linked to hospital outcome
data. Multiple regression analyses were used to compare the performance of APACHE II and the
Charlson index.
Results: The Charlson index was a poor predictor of mortality (C = 0.626). There was minimal
difference between a baseline model containing age, sex and acute physiology score (C = 0.74) and
models containing either chronic health points (C = 0.76) or Charlson index variations (C = 0.75,
0.76, 0.77). No important improvement in prediction occurred when the Charlson index was
added to the full APACHE II model (C = 0.808 to C = 0.813).
Conclusion: The Charlson index does not perform as well as the APACHE II in predicting hospital
mortality in ICU patients. However, when acuity of illness scores are unavailable or are not
recorded in a standard way, the Charlson index might be considered as an alternative method of
risk adjustment and therefore facilitate comparisons between intensive care units.
Background
In health services research, risk adjustment is important to
account for variations in case-mix that might affect assess-
ment of outcomes, therefore allowing comparisons to be
made between health care providers and health systems
locally and globally. In the intensive care unit (ICU), risk
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adjustment and mortality prediction has usually been per-
formed using severity score taxonomies such as the Acute
Physiology and Chronic Health Evaluation (APACHE)
score, the Simplified Acute Physiology Score (SAPS) or the
Mortality Prediction Model (MPM) [1-3], and their
updated derivatives [4-8]. These systems emphasize the
severity of physiologic derangement, but also include, to
a variable degree and weight, some measure of pre-exist-
ing illness. For example, the APACHE II system assigns 0,
2 or 5 chronic health points (CHP) for pre-existing co-
morbidity out of a possible 73 total points [4]. Since the
emphasis of all these systems is the measurement of phys-
iological derangement, the small consideration of pre-
existing disease may not adequately account for the quan-
titative or qualitative contribution of co-morbid illness,
thus limiting the ability of these models to accurately pre-
dict mortality [9].
A significant limitation to severity of illness scores is that
data collection is labour intensive and expensive, and the
necessary data to calculate these scores are unlikely to be
found in administrative databases. Therefore, the utility of
these scores in risk adjustment is limited to prospective
studies including clinical trials. It is unlikely that these
scores can be accurately calculated for use in retrospective
studies such as for benchmarking, quality assurance, or to
examine differences in service delivery within a city, coun-
try or between countries. Other systems, used widely out-
side critical care, have been developed to predict patient
outcomes based solely on the presence of predefined
existing co-morbidities. For instance the Charlson index
assigns weighted scores to 17 co-morbidities ranging from
chronic heart failure to HIV infection [10]. Classification
within systems like the Charlson index originally required
a chart review, and therefore was also costly and labour
intensive. However, recent work has validated the deter-
mination of these scores from administrative data, per-
mitting quick, easy, and inexpensive calculation.
Therefore, these scores can be determined for prospective
and retrospective studies.
Small studies have suggested that the Charlson index may
perform comparably or better than APACHE II for mortal-
ity prediction in an ICU population [11,12]. Poses et al
[11] suggested that the Charlson index could improve
prognostic predictions in ICU patients when added to the
APACHE II. However, their study was conducted in only
one hospital with data collected manually by chart review
over a short interval. There is little data on the validity and
utility of the Charlson index, calculated using administra-
tive data, as a risk adjustment method for ICU patients
[13]. Therefore, the purpose of this study was to compare
the performance of the Charlson index alone and in com-
bination with components of APACHE II for predicting
hospital mortality among adult ICU patients.
Methods
Study Population
The Calgary Health Region (CHR) exclusively provides in-
hospital acute care to all residents of the Calgary Health
Region (city of Calgary and approximately 20 nearby
small towns, villages, and hamlets total population
approximately 990,000 in 2002). The CHR Department
of Critical Care Medicine provides care to critically ill
patients in three closed multidisciplinary and 1 closed car-
diovascular intensive care units (ICUs). The base study
population consisted of all adult (>17 years) CHR resi-
dents admitted to any multidisciplinary ICU in the CHR
between April 1st 2002 and March 31st 2004. Cardiovas-
cular surgery patients (n = 2541) were excluded because
they differed from other ICU patients with respect to their
physiologic derangement, mortality rate, and the utility of
the APACHE II system for predicting mortality in this sub-
group. During the study period, the first admission of a
patient to the ICU and their subsequent hospital stay was
considered the index admission. All data were analyzed
for the index admission only. The study was approved by
the local human research ethics committee. Individual
patient consent was waived as the final study sample con-
tained no individual patient identifiers following the link-
age described below.
Design and Data Sources
This study used a population-based cohort design that
linked clinical and outcome data from two large adminis-
trative databases. Demographic, physiological, diagnostic
and treatment data for study participants during their ICU
stay were recorded prospectively using the Quantitative
Sentinel (QS) 6.6.9 Clinical Information System (GE Mar-
quette Medical Systems INC., Milwaukee, WI) and stored
in a locally developed longitudinal relational database
called ICU Tracer, which is built on an Oracle Enterprise
platform (Oracle Corporation, Redwood Shores, CA).
Details about the Tracer database have been previously
published [14]. Patients were identified in the Tracer data-
base, and their demographics and clinical data were then
linked to hospital discharge data obtained from the CHR
administrative database through a deterministic record
linkage using last name, date of birth, ICU admit date,
ICU discharge date and unique provincial healthcare
number (PHN). The administrative hospital discharge
data contained up to 16 secondary diagnosis codes and
types as well as 10 procedure codes, which were used to
derive the Charlson index. Using the ICD-10-CM code
taxonomy to identify diagnoses and procedures, we
excluded the diagnosis type with M (main diagnosis) or a
2 (post admit co-morbidity) because these conditions
were the cause or consequence of the hospital admission,
and not a pre-existing comorbidity. The linkage rate was
99%. All individual patient personal identifiers were
stripped following linkage.BMC Health Services Research 2009, 9:129 http://www.biomedcentral.com/1472-6963/9/129
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Main Outcome Measure and Variables
The primary outcome was all cause hospital mortality.
The APACHE II score was collected prospectively at the
time of ICU admission in accordance with the original
published recommendations [4]. At ICU admission, the
attending critical care physician, using a standardized
automated entry system with on-line operational defini-
tions, determined the diagnosis responsible for ICU
admission, the Glasgow coma score (based on the best
assessment of neurological status excluding any potential
confounding effect of medications), and the CHP compo-
nent. The physiologic and laboratory data required to cal-
culate the acute physiology score (APS) component of the
APACHE II were obtained by automated electronic down-
load from physiologic monitors or laboratory informa-
tion systems. Variables from physiologic monitors
required validation by nursing staff prior to download.
The calculation of APS was based on the worst value for
each variable within the 24 hours of ICU admission. The
Charlson index consists of 17 co-morbidities, which are
weighted and summed to produce a score [10]. We used
the ICD-10 coding algorithms developed by Quan et al.
[15] to derive a co-morbidity score for each patient. In this
multi-step process, ICD-10 coding algorithms were devel-
oped by translating the ICD-9-CM codes derived from
Deyo's method [16]. The validity of the algorithms for
ICD-10 coding from administrative data has been previ-
ously reported [15].
Statistical Analysis
Baseline characteristics including the frequency of Charl-
son comorbidities were calculated for the cohort of
patients. Univariate analysis was used to compute the C-
statistic for models containing CHP, Charlson index score
and APACHE II alone. Four separate nested multivariate
logistic regression models were constructed. The baseline
model consisted of age, sex and APS (Model A). To this
baseline model, were then added individually CHP
(Model B), the Charlson co-morbidities as individual
entities (Model C), and the Charlson index as a weighted
score in the same categories as suggested by D'Hoore (1–
2, 3–4, 5–6, >6) (Model D) [17]. Finally, as the relation-
ship between the Charlson index and the log odds of
death was non-linear the Charlson index was recoded
excluding scores of 6 and above (Model E). Finally, the
discriminative ability of the full APACHE II score (Model
F) was examined with the addition of the weighted Charl-
son index score (Model G). The C-statistic was used to dis-
criminate between patients who would live and die and
represents the area under the curve for the probability that
the mortality status of a randomly selected survivor and
non survivor is identified correctly by a given prediction
model [18]. C-statistics of 0.8 to 0.9 are regarded as very
good, 0.7 to 0.8 are considered adequate and C-statistics
below 0.7 are regarded as poor [19]. To test whether the
addition of co-morbidity variables improved the explana-
tory ability of the nested models changed significantly,
likelihood ratio tests (LR) were used [20]. The LR test was
computed as twice the difference between the log-likeli-
hood from the two models being compared, and the sta-
tistic derived was compared to a χ2  (chi-squared)
distribution for significance testing. Since model perform-
ance can be degraded by inclusion of many predictors, we
calculated Akaike's Information Criterion (AIC). This sta-
tistic provides a method for penalizing the log likelihood
to gain an unbiased assessment of the model's perform-
ance after inclusion of additional predictors. To calculate
the AIC, we added twice the number of parameters to the
-2 log likelihood [20]. Goodness of fit was assessed by
graphical means and by the Hosmer and Lemeshow's
Goodness of Fit test. Finally, Efron's enhanced bootstrap-
ping method was performed to estimate the amount of
shrinkage in the models [21]. Finally, we explored the
effect of re-weighting the individual co-morbidities within
the Charlson index based on their odds ratio of being
associated with hospital mortality. All statistical analyses
were preformed using SAS version 9.1 (Cary, NC) and
STATA 9.2 (College Station, Texas).
Results
During the two year study period, there were 3778 eligible
index admissions into the multi-disciplinary ICUs.
Table 1: Patient Characteristics
Age (y)
Mean ± SD* 56.9 ± 19.7
Sex (%)
Male 2142 (57.0)
Female 1615 (43.0)
Unknown 21 (0.50)
Length of ICU stay (days)
Median (IQR)† 2.8 (1.2,6.4)
Admitting APACHE II Score
Mean ± SD 19.6 ± 8.6
First TISS score‡
Mean ± SD* 35.0 ± 14.0
In hospital Mortality (%)
Frequency 1026 (27.2)
ICU mortality (%)
Frequency 712 (18.9)
Charlson Index Score
Median (IQR; maximum)† 1 (0,2;13)
Chronic Health Points (%)
0 2643 (70.0)
2 95 (2.5)
5 985 (26.1)
Unknown 55 (1.5)
APS
Mean ± SD 15.2 ± 7.7
Total sample size = 3778, unless otherwise stated.
*SD = standard deviation
†IQR = interquartile range
‡TISS = Therapeutic Intervention Scoring SystemBMC Health Services Research 2009, 9:129 http://www.biomedcentral.com/1472-6963/9/129
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Patient characteristics are described in Table 1. Patients
had an average age of 56.9 years, with a slightly higher
percentage of males (57.0%). The mean (± SD) admitting
APACHE II and APS scores were 19.6 (± 8.6) and 15.2 (±
7.7) respectively. The ICU and hospital mortality rates
were 18.9% and 27.2% respectively. According to the
CHP classification 26.5% of patients had severe chronic
health problems. The Charlson index was highly skewed
with 77.0% of the observations between 0 and 2. Forty
one percent of patients (41.3%) had no co-morbidities,
28.8% had a single co-morbidity, 25.6% had two or three
co-morbidities and 3.7% of patients had four or more co-
morbidities.
The prevalence of co-morbidities, the Charlson weight,
and the association of the co-morbidity with hospital
mortality are presented in Table 2. The most common co-
morbidity was either chronic pulmonary or cardiac dis-
ease, followed by diabetes. The only disease with a preva-
lence of less than 1% was known pre-existing seropositive
HIV status. In the original Charlson classification, co-mor-
bidities with odds ratio associated with mortality of
≥1.2<1.5 were assigned a weight of 1, conditions with a
ratio of ≥1.5<2.5 a weight of 2, conditions with ≥2.5<3.5
a weight of 3, conditions with ≥3.5<4.5 a weight of 4, and
those conditions with weights of 6 or more were assigned
a weight of 6. A 'recoded' ICU weight based on the odds-
ratio of the co-morbidity demonstrated in this study sam-
ple that 7 of the co-morbidities would be assigned a
weight of zero, 3 co-morbidities (cerebrovascular disease
and liver disease (mild and moderate or severe)) would
have a larger weight, 4 variables would have smaller
weights (cancer and metastatic cancer, HIV seropositive
status, and paraplegia-hemiplegia) and only 2 co-morbid-
ities would not change their weight (myocardial infarc-
tion and peripheral vascular disease).
Table 3 displays the models constructed to predict hospi-
tal mortality. The CHP component of APACHE II alone
was not a good univariate predictor of hospital mortality
(C = 0.594). The Charlson index was a slightly better pre-
dictor (C = 0.626). In contrast, the full APACHE II was a
good predictor of hospital mortality (C = 0.808). No fur-
ther gain in discrimination was detected when the Charl-
son index was added to the full APACHE II model (C =
0.808 to C = 0.8135). In the nested multivariable models,
the baseline model of age, sex and APS (Model A) per-
formed reasonably well (C = 0.743). In each of the 3 sub-
sequent nested models (Models B, C, or D) which added
a measure of chronic health status to the baseline model,
a statistically significant improvement in the model's dis-
criminative ability to predict hospital death was observed
(Model B, C = 0.757, Model C, C = 0.768, Model D, C =
0.752, p < 0.0001 each Model relative to Model A). How-
ever, the increase in discriminative ability would be con-
sidered of minimal practical significance. The Charlson
Table 2: Estimation of logistic regression parameters to predict in-hospital death
Co-morbidity Charlson weight Persons with co-
morbidity(%)
OR (95%CI) ICU weight † Hospital mortality 
associated with individual 
co-morbidity(%)
Chronic pulmonary 
disease
1 16.38 0.84 (0.67, 1.04) 27.46
Congestive heart failure 1 12.92 1.06 (0.84, 1.33) 35.86
Diabetes without 
complications
1 12.44 0.77 (0.61, 0.98) 29.15
Myocardial infarction 1 10.03 1.47 (1.15, 1.89) 1 40.94
Renal disease 2 7.41 1.37 (1.02, 1.84) 1 40.00
Cerebrovascular disease 1 6.14 1.75 (1.28, 2.38) 2 40.94
Cancer 2 5.64 1.46 (1.06, 2.00) 1 40.38
Peripheral vascular 
disease
1 5.61 1.30 (0.94, 1.80) 1 41.51
Paraplegia and hemiplegia 2 4.71 1.27 (0.88, 1.83) 1 32.02
Metastatic carcinoma 6 5.64 1.50 (1.06, 2.13) 2 62.96
Mild liver disease 1 4.08 2.50 (1.69, 3.70) 2 52.60
Diabetes with 
complications
2 4.08 0.63 (0.42, 0.96) 29.22
Moderate or severe liver 
diseases
3 2.86 3.85 (2.41, 6.14) 4 62.96
Dementia 1 2.38 0.70 (0.43, 1.14) 33.33
Peptic ulcer disease 1 2.17 0.87 (0.51, 1.48) 31.70
Connective tissue-
rheumatic diseases
1 1.85 0.91(0.52, 1.60) 31.43
HIV 6 0.11 1.26(0.11, 14.2) 1 25.00
† ICU weights calculated from logistic regression model. A blank space means that a null value was assigned to this co-morbidity.BMC Health Services Research 2009, 9:129 http://www.biomedcentral.com/1472-6963/9/129
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index scores above 6 did not demonstrate a linear rela-
tionship with the log odds of death (Figure 1). Therefore,
a post-hoc modification was performed where individual
subjects with a Charlson index score of 6 and above were
excluded (Model E). This analysis also demonstrated a sta-
tistical (C = 0.757) but not practical improvement in the
discriminative ability to predict hospital death compared
to the baseline model. Model B (assessment of the contri-
bution of individual co-morbidities) was the most com-
plex model with the largest AIC of 100.6. In contrast,
when the Charlson index weighted scores were included
(Models C and D), there was only a moderate increase
(AIC = 38.90, AIC = 9.92 respectively).
Figure 2 shows a scatter plot of the expected vs. observed
number of deaths for the Charlson index using the
D'Hoore cut points (Model D). Data points falling on the
45 degrees line indicate perfect calibration. Most of the
data points fell on or close to the line indicating fairly
good calibration; both Models B and C had similar graphs
(not shown).
Discussion
The objective of this study was to assess the performance
of the Charlson index alone and in combination with
components of the APACHE II for predicting hospital
mortality among adult ICU patients. Our results show as
expected that the full APACHE II model performed the
best of all models in predicting hospital mortality. The
discrimination of the APACHE II model in our data (C =
0.808) was similar to the results from other large studies
of similar duration and size [22], and similar to the results
of other specific ICU acuity of illness taxonomies such as
SAPS or MPM. A baseline model of age, sex, and APS pro-
vided good discriminative ability to predict mortality (C =
0.743). The addition of the Charlson co-morbidity com-
ponents added little to either the baseline model, or to the
full APACHE II model. Further, these results demonstrate
and it is reasonable to conclude that adding or replacing
the APACHE II CHP with the Charlson index provides no
practical improvement to the discriminative ability of
such a predictive model (C = 0.808 vs C = 0.813). Our
results are similar to those published by Ho et al. These
investigators from Royal Perth Hospital (which provides
ICU care to a large region of Western Australia) demon-
strated that more comprehensive measures of co-morbid-
ity did not significantly improve the discrimination of the
APACHE II score [23].
It may not be surprising that the Charlson index did not
perform as well as APACHE II. APACHE II was originally
developed and validated in ICU patients, whereas the
Charlson index was developed using 1 year survival data
on medical in-patients, with subsequent analysis assess-
ing its ability to predict survival over 10 years for breast
cancer patients. Since the population groups and out-
comes are different, the weights applied in the Charlson
index may not be appropriate for critically ill patients. For
example, our data demonstrated that only 10/17 Charl-
son co-morbidities were associated with an increased risk
of hospital death. Myocardial infarction and peripheral
vascular disease were the only 2 co-morbidities that had
the same original Charlson weights. Co-morbidities with
an infrequent prevalence (less than 3%) such as dementia,
connective tissue-rheumatic disease, and peptic ulcer dis-
ease were not associated with mortality, while HIV was
assigned a much smaller weight compared to the original
Charlson index. It may be that some of the co-morbidi-
ties, such as dementia, were associated with a clinical deci-
sion to exclude ICU admission, but our data can not
ascertain if this form of selection bias was present, or if
present, its potential magnitude. Another alternate expla-
nation is that since the Charlson index was derived in
1987, advances in the treatment and therefore risk of mor-
tality for some co-morbidities, for instance HIV/AIDS, has
changed. Therefore, the current weights applied in the
Charlson index may not be appropriate.
This study showed the Charlson index had a non-linear
relationship with the odds of mortality, results similar to
a study in ischemic heart patients [17]. The distribution of
Charlson index scores in our results was skewed, with
77.23% of patients assigned a score of two or less. The
small number of ICU patients in our sample with high
Charlson index scores may explain why the estimate was
unstable in this subset. Our results differ from those of
Poses et al., who demonstrated that the Charlson index, as
a univariate predictor, had a linear relationship with hos-
pital mortality for ICU patients [11]. The disparity in
results may be due to their small sample size, (N = 201),
or differences in the methods of calculating the Charlson
The relationship between the odds of death for the Charlson  score and categories was linear for index scores of 4 or less,  but this relationship was no longer consistent for scores  above 4 Figure 1
The relationship between the odds of death for the 
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Index as their results report a labor intensive chart review
rather than the use of administrative data [11].
The present study had several strengths. All critically ill
patients admitted to an ICU in the CHR during the study
period were included in the sample, therefore reducing
susceptibility to selection bias from referral, but not nec-
essarily excluding bias in cases where critically ill patients
were refused admission to ICU based on underlying co-
morbidities and probability for death. Unfortunately, we
do not have a method of determining if this occurred.
Over-fitting of the models was reduced because we
excluded complications using the diagnosis type indicator
in the administrative data and this was assessed by boot-
strapping methodology. Furthermore, we had a large sam-
ple size (N = 3778) and sufficient hospital mortality
(27.1%), which produced stable estimates of coefficients
that were less susceptible to shrinkage. Our study suggests
that ICU specific weights may be quite different than the
original Charlson weights, and these results should serve
as caution to health service researchers when using the
Charlson index as risk adjustment measure in ICU
patients.
Table 3: Model Performance for Predicting In-hospital Mortality
Model Log Likelihood Degrees of 
Freedom
P value for LR Likelihood Ratio 
Test
C stat AIC
(LR-2xdf)
Mean Shrinkage
Model A 
(Baseline model)
age sex APS *
-1882.01 0.743 0.97
Model B
age sex APS CHP†
-1843.92 1 <0.0001 76.17 0.757 74.17 0.97
Model C
Age, sex, APS, c. 
cob‡
-1814.69 17 <0.0001 134.64 0.768 100.64 0.94
Model D 
(D'Hoore)
Age, sex, APS, 
Charlson score
-1861.56 1 <0.0001 40.89 0.752 38.89 0.98
Model E
Age, sex, APS, 
Charlson score 
(excluded scores 6 
and above)
-1701.14 1 <0.0001 11.92 0.757 9.92 1.01
Model F
APACHE II, 
Charlson score
-1652.67 0.813 0.99
Model G
APACHE II 
(with diagnosis)
-1670.11 0.808 1.00
*APS is the acute physiology score derived from APACHE II by subtracting the age and the CHP components
† CHP is the Chronic Health Points from the APACHE II score.
‡Charlson co-morbidities entered as individual dummy variables
This graph is a plot of observed and expected risk groups for  each decile of in-hospital mortality Figure 2
This graph is a plot of observed and expected risk 
groups for each decile of in-hospital mortality. 
Observed points falling on the line show good calibration for 
Model D.  Points falling above the line show that the model 
underestimated the actual risk of death.
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Although the Charlson index alone did not perform as
well (C = 0.626) as the full APACHE II, we do not believe
our results preclude its use for risk adjustment in admin-
istrative data in the absence of ICU acuity of illness scores.
The collection of ICU acuity of illness scores is labour
intensive and therefore costly. The validity of collecting
APACHE II data from retrospective chart review has not,
to our knowledge, been validated (for example, accurate
assessment of Glasgow coma score may be very difficult).
In contrast, the Charlson index is well suited for use in
administrative datasets, and algorithms developed to
recode administrative collected and coded diagnosis data
into a Charlson index has been well studied and validated
[8,9]. Therefore, the Charlson index may have practical
applications when APACHE II or other acuity scores have
not been prospectively determined, or have been deter-
mined in a non-standard manner. Furthermore, age and
sex are data nearly always available in administrative data-
sets. When we analyzed the Charlson index with age and
sex, the C-statistic increased to 0.68 (analysis not pre-
sented), supporting the utility of the Charlson index as a
risk adjustment method in the absence of ICU based acu-
ity scores. The Charlson index may also have some useful-
ness in comparing outcomes between ICU patient
populations where the same acuity of illness score has not
been used. Finally, the utility of ICU acuity illness scores
in the assessment of outcome beyond hospital discharge
has not been well established, whereas, the Charlson
index is an accepted method of risk adjustment in longer
term outcome studies in non-ICU patients. Future studies
should explore the Charlson index's ability to predict
longer term outcomes in ICU and whether modification
of the Charlson index could help improve the perform-
ance of this risk adjustment method in intensive care data.
Conclusion
The Charlson index does not perform as well as the
APACHE II in predicting hospital mortality in ICU
patients. However, when acuity of illness scores are una-
vailable or are not recorded in a standard way, the Charl-
son index might be considered as an alternative method
of risk adjustment and therefore facilitate comparisons
between intensive care units.
Key messages
￿ When comparing health care delivery between ICUs
risk adjustment methods are required.
￿ A well validated method of calculating Charlson
index scores from administrative data can be used to
obtain Charlson scores for individual ICU patients
without an expensive, labour intensive chart review.
￿ Although the Charlson index does not perform as
well at predicting in-hospital mortality among ICU
patients as the APACHE II, the Index could be used
when acuity of illness scores are unavailable or are not
recorded in a standard way.
￿ Future studies should compare the ability of the
Charlson index and the APACHE system to predict
longer term outcomes in ICU.
￿ In addition, recalculating and updating Charlson
weights could help to improve performance of this
risk adjustment method in intensive care data.
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